Executive Director Product Development
Avadel
Thorsteinn Thorsteinsson Ph.D., Executive Director Product Development, Avadel Pharmaceuticals
With more than 20 years of pharmaceutical experience, Dr. Thorsteinsson has published 16 articles in peer-reviewed journals, has 21 issued patents and over 50 podium and poster presentations at regional, national and international society meetings. From 2018 to 2023 he was an independent consultant for many pharmaceutical companies, helping them advancing drug discovery and approvals. Prior to that, he held a Senior Vice President of Research & Development position at Sancilio & Company, Inc. (SCI) from 2012 - 2018, where he invented and developed Advanced Lipid Technologies® platform and Imvexxy® vaginal soft gelatin capsules. Leading several groups, like Formulation, Analytical, Regulatory and Technical Services, for multiple INDs, NDAs and ANDAs.
Prior to joining SCI in 2012, he was leading formulation activities at Banner Pharmacaps (Later Patheon), developing soft gelatin capsules for NDAs and ANDAs filings. Dr. Thorsteinsson has hands on experience in developing high quality products for FDA approval. He earned his Ph.D. at the School of Pharmacy at the University of Iceland.